PSA stands for prostate-specific antigen, a protein produced by the prostate gland. It’s best known as a blood test used to screen for prostate cancer, but PSA levels can rise for many reasons that have nothing to do with cancer. Understanding what PSA actually measures, what the numbers mean, and what happens if your level is high can help you make sense of a result that often causes more confusion than it should.
What PSA Actually Does in the Body
PSA is a protein whose main job has nothing to do with cancer detection. It’s produced by cells in the prostate and secreted into semen, where it breaks down proteins that cause semen to clot after ejaculation. This liquefaction helps sperm move freely.
Small amounts of PSA naturally leak from the prostate into the bloodstream. When the prostate is healthy, that amount is minimal. But anything that disrupts, enlarges, or inflames prostate tissue can push more PSA into the blood, raising your level on a blood test. That’s why a high PSA doesn’t automatically point to cancer. It simply means something is affecting the prostate.
What’s Considered a Normal PSA Level
PSA is measured in nanograms per milliliter (ng/mL) of blood. There’s no single “normal” number for all men because PSA naturally rises with age as the prostate grows. According to Johns Hopkins Medicine, the expected ranges break down roughly like this:
- Men in their 40s and 50s: The median PSA is 0.6 to 0.7 ng/mL. A reading above 2.5 ng/mL is generally considered elevated.
- Men in their 60s: The normal range is between 1.0 and 1.5 ng/mL, with readings above 4.0 ng/mL considered elevated.
These thresholds are guidelines, not hard boundaries. A man in his 40s with a PSA of 3.0 may warrant closer attention than a man in his 70s with the same number, simply because it’s unusually high for his age.
Why PSA Can Be High Without Cancer
An elevated PSA result causes understandable anxiety, but many common, non-cancerous conditions raise PSA levels. An enlarged prostate (benign prostatic hyperplasia, or BPH) is one of the most frequent causes, especially in men over 50. More prostate tissue simply means more PSA-producing cells. Prostatitis, an inflammation or infection of the prostate, can spike PSA dramatically. One case report documented a benign prostatic cyst that pushed PSA to 79 ng/mL with no cancer present at all.
Urinary tract infections in men also elevate PSA. Even a digital rectal exam, where a doctor presses on the prostate through the rectum, can temporarily nudge the number upward. Surprisingly, elevated PSA has even been found in patients experiencing cardiogenic shock who had no prostate disease whatsoever. The takeaway: a single high reading tells you very little on its own.
How Doctors Look Beyond a Single Number
When your PSA comes back elevated, doctors use several additional tools to figure out whether cancer is a real concern or something benign is responsible.
PSA Velocity
This tracks how fast your PSA rises over time. A slow, gradual increase is expected with age. A jump of more than 0.75 ng/mL per year, or more than 25% annually, raises suspicion. Calculating PSA velocity requires at least three separate blood draws spread over 18 months or longer, so it’s not something you can assess from a single test.
PSA Density
This compares your PSA level to the size of your prostate, measured by ultrasound or MRI. A larger prostate naturally produces more PSA, so dividing the PSA number by the prostate’s volume helps account for that. A PSA density of 0.15 or higher is considered suspicious for cancer.
Free PSA Percentage
PSA circulates in two forms: “free” (unattached) and “bound” (attached to other proteins). Cancer tends to produce more bound PSA, so a lower percentage of free PSA relative to total PSA suggests a higher cancer risk. For men with PSA levels between 4.0 and 10.0 ng/mL, a free PSA percentage of 25% or less is the typical threshold that prompts further investigation. The lower that percentage drops, the higher the concern.
What Happens After an Elevated Result
If your PSA comes back high, the first step is usually straightforward: repeat the test in a few weeks. Temporary spikes from infection, inflammation, or recent physical activity often resolve on their own. If the level stays elevated, the next steps typically follow a predictable path.
Your doctor may order a prostate MRI, which can identify suspicious areas within the gland and help determine whether a biopsy is needed. Newer biomarker tests using blood or urine samples can also estimate how likely a biopsy is to find cancer, helping you and your doctor decide whether that step is necessary.
A biopsy, where small tissue samples are taken from the prostate for lab analysis, remains the only way to confirm prostate cancer. If an MRI has already flagged concerning areas, the biopsy can target those specific spots rather than sampling the prostate randomly, which improves accuracy.
When Screening Is Recommended
PSA screening guidelines differ depending on who you ask, but they share a common theme: screening should be a personal decision, not an automatic one.
The U.S. Preventive Services Task Force recommends that men aged 55 to 69 discuss the potential benefits and harms of PSA screening with their doctor before deciding. The task force explicitly advises against screening men 70 and older, concluding that the risks of overdiagnosis and unnecessary treatment outweigh the benefits at that age.
The American Cancer Society takes a slightly different approach, recommending that the conversation about screening begin at different ages based on risk:
- Age 50 for men at average risk who are expected to live at least 10 more years
- Age 45 for men at higher risk, including Black men and men with a father or brother diagnosed with prostate cancer before age 65
- Age 40 for men at the highest risk, such as those with multiple first-degree relatives diagnosed at an early age
The reason screening is a conversation rather than a blanket recommendation is that many prostate cancers grow so slowly they would never cause symptoms or shorten a man’s life. Detecting them through screening can lead to treatments with significant side effects, including urinary incontinence and sexual dysfunction, for a cancer that may never have needed treatment. On the other hand, screening does catch aggressive cancers earlier, when they’re most treatable. That tradeoff is why the decision ultimately depends on your age, risk factors, and personal priorities.